Literature DB >> 26612262

Evaluation of (99m)Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders.

Babak Fallahi1, Atefe Esmaeili1, Davood Beiki2, Shahram Oveisgharan3, Hamid Noorollahi-Moghaddam3, Mostafa Erfani4, Abbas Tafakhori5, Mohammad Rohani6, Armaghan Fard-Esfahani1, Alireza Emami-Ardekani1, Parham Geramifar1, Mohammad Eftekhari1.   

Abstract

OBJECTIVE: Parkinson disease (PD), parkinsonian syndromes (PS) and essential tremor (ET) are different types of movement disorders which share some symptoms resulting in a difficulty of certain diagnosis. This study was conducted to determine the value of (99m)Tc-TRODAT-1 scan to differentiate PD from ET and other PS cases.
METHODS: Totally, 75 patients were studied including 29 PD, 6 possible PD, 22 ET and 18 PS cases. A dual-head SPECT-CT was used to perform basal ganglia (BG) imaging following administration of (99m)Tc-TRODAT-1. The BG uptake values were normalized to whole brain and occipital activity. All patients were followed for 2-22 months to reach a certain diagnosis.
RESULTS: Patients with ET and drug-induced parkinsonism show significantly higher normalized BG uptake as compared to the other subgroups; however, no significant difference was noted between PD and PS patients. The sensitivity and specificity of the findings for the differentiation between patients with the disease associated versus not associated with BG dysfunction were 80 and 83.3%, respectively. A predictive positive value of 82.6% was obtained using an additive scaling index defined as asymmetry and unevenness of uptake in putamen and/or caudate contralateral to the dominant side of current symptoms.
CONCLUSIONS: (99m)Tc-TRODAT-1 scan is an appropriate method to differentiate PD or PS versus ET. A combination of scan pattern including asymmetry of BG uptake and unevenness of activity in caudate and putamen along with the side of dominant symptoms may be valuable for the differentiation of Parkinson's disease from the other parkinsonian syndromes.

Entities:  

Keywords:  99mTc-TRODAT-1; Essential tremor; Parkinsonian syndrome; Parkinson’s disease; SPECT

Mesh:

Substances:

Year:  2015        PMID: 26612262     DOI: 10.1007/s12149-015-1042-y

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  4 in total

Review 1.  Highlights of articles published in annals of nuclear medicine 2016.

Authors:  Hossein Jadvar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-28       Impact factor: 9.236

2.  99mTc-TRODAT-1 SPECT Imaging in Early and Late Onset Parkinson's Disease.

Authors:  Payam Sasannezhad; Ali Ghabeli Juibary; Kayvan Sadri; Ramin Sadeghi; Mahsa Sabour; Vahid Reza Dabbagh Kakhki; Hesam Alizadeh
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

Review 3.  Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?

Authors:  Rodolfo Ferrando; Andres Damian
Journal:  Front Neurol       Date:  2021-05-10       Impact factor: 4.003

4.  Extra-striatal ptake of 99mTc-TRODAT SPECT in a erebral eningioma: A Case Report.

Authors:  Mahsa Sabour; Ali Shoeibi; Somayeh Ghahremani; Ramin Sadeghi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.